DK
Devendra Kumar Shukla
About Devendra Kumar Shukla
Data last updated:
Devendra Kumar Shukla is a Director at Godcare Pharma Private Limited (since 2020) and Additional Director at Mucosis Life Sciences Private Limited (since 2022). The companies operate in Chemicals. The largest current company by reported revenue is Godcare Pharma Private Limited at ₹70,094 (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Jan 2020 | 2020 | ₹70,094 (FY 2022) | Active | |
| Additional Director | 19 May 2022 | 2020 | Active |
Board colleagues of Devendra Kumar Shukla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sunit Kumar Shukla | 09600571 | Godcare Pharma Private Limited , Mucosis Life Sciences Private Limited | Director |
| Ashutosh Singh | 08724749 | Mucosis Life Sciences Private Limited | Director |
| Sachin Digvijay Shukla | 09599018 | Mucosis Life Sciences Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Devendra Kumar Shukla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devendra Kumar Shukla
Devendra Kumar Shukla currently holds 2 directorships: Godcare Pharma Private Limited (Director, since 14 Jan 2020, revenue ₹70,094 (FY 2022)); Mucosis Life Sciences Private Limited (Additional Director, since 19 May 2022).
Devendra Kumar Shukla was first appointed on 14 Jan 2020 as Director at Godcare Pharma Private Limited. The most recent appointment on record is 19 May 2022 at Mucosis Life Sciences Private Limited.
The current boards of Devendra Kumar Shukla's companies include Sunit Kumar Shukla (Godcare Pharma Private Limited), Ashutosh Singh (Mucosis Life Sciences Private Limited), Sachin Digvijay Shukla (Mucosis Life Sciences Private Limited).